Find a Tender · Contract
NP47725a Emicizumab (Indication Specific)
A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) via Find a Tender.
- —
- Award value
- —
- Tender value
- 1
- Suppliers
- 2
- Awards
- 2
- Notices
- Contract
- Stage
Overview
Supply of Emicizumab (Indication Specific) to NHS Scotland.
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- complete
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- —
- First published
- 18 Sept 2025
- Last updated
- 27 Oct 2025
Awards
2 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Roche Products Ltd | 00100674 | — | active | — |
| Roche Products Ltd | 00100674 | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
FAQs about this procurement
Who is the buyer for "NP47725a Emicizumab (Indication Specific)"?
NP47725a Emicizumab (Indication Specific) is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) via Find a Tender.
Has "NP47725a Emicizumab (Indication Specific)" been awarded?
Yes — 2 awards are recorded. The current lifecycle stage is "Contract".
Which suppliers are involved in "NP47725a Emicizumab (Indication Specific)"?
1 supplier is linked: Roche Products Ltd.
When was "NP47725a Emicizumab (Indication Specific)" published?
It was first published on 18 Sept 2025 and last updated on 27 Oct 2025, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable